Trial Profile
A retrospective study to evaluate the safety and efficacy of telbivudine in preventing mother-to-child transmission (MTCT) of hepatitis B virus (HBV) in HBeAg-positive pregnant women with high viral load
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 15 Dec 2015 New trial record